[
  {
    "title": "Vertex keeps outlook unchanged as income and revenue rise",
    "published": 1715097240,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.5391807556152344
  },
  {
    "title": "Q1 2024 Vertex Pharmaceuticals Inc Earnings Call",
    "published": 1715089841,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.6589323282241821
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $18 at Leerink, here's why",
    "published": 1715079180,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7024036049842834
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $7 at RBC Capital, here's why",
    "published": 1715070600,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7107131481170654
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $11 at UBS, here's why",
    "published": 1715068620,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7293819189071655
  },
  {
    "title": "Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)",
    "published": 1715066280,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9144737124443054
  },
  {
    "title": "Piper Sandler Releases a Buy Rating on Vertex Pharmaceuticals (VRTX)",
    "published": 1715065740,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9108092784881592
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital",
    "published": 1715065680,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9371644854545593
  },
  {
    "title": "Buy Rating on Vertex Pharmaceuticals: Promising Kidney Disease Treatments Poised for Market Growth",
    "published": 1715065380,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9459986686706543
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $6 at Piper Sandler, here's why",
    "published": 1715060160,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7308400869369507
  },
  {
    "title": "Buy Rating Affirmed for Vertex Pharmaceuticals on Strong Q1 Earnings and Expanding Market Presence",
    "published": 1715052360,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9552577137947083
  },
  {
    "title": "UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments",
    "published": 1715034798,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9421020746231079
  },
  {
    "title": "Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript",
    "published": 1715031062,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.8932909965515137
  },
  {
    "title": "Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key",
    "published": 1715029147,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.941871702671051
  },
  {
    "title": "Vertex Reports First Quarter 2024 Financial Results",
    "published": 1715025660,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.8881224393844604
  },
  {
    "title": "Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug",
    "published": 1715013512,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9292699098587036
  },
  {
    "title": "Smart Money Is Betting Big In VRTX Options",
    "published": 1714994460,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.6995221376419067
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Owens & Minor (OMI), Vertex Pharmaceuticals (VRTX) and Aldeyra Therapeutics (ALDX)",
    "published": 1714972860,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9101052284240723
  },
  {
    "title": "Vertex provides another EPS beat as net income rises 56% in Q1",
    "published": 1714969320,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9451616406440735
  },
  {
    "title": "Vertex Pharmaceuticals affirms FY4 revenue view of $10.55B-$10.75B",
    "published": 1714964640,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.6595264077186584
  },
  {
    "title": "Noteworthy Monday Option Activity: VRTX, VRT, BOWL",
    "published": 1714962720,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9119530916213989
  },
  {
    "title": "Insider Sale at Vertex Pharmaceuticals Inc (VRTX): Director Sangeeta Bhatia Sells Shares",
    "published": 1714777267,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 401.5,
      "2024-05-03T14:30:00+00:00": 399.70001220703125,
      "2024-05-03T15:30:00+00:00": 399.93499755859375,
      "2024-05-03T16:30:00+00:00": 400.2200012207031,
      "2024-05-03T17:30:00+00:00": 401.6600036621094,
      "2024-05-03T18:30:00+00:00": 402.04998779296875,
      "2024-05-03T19:30:00+00:00": 402.1099853515625
    },
    "sentiment": 0.8833467364311218
  },
  {
    "title": "June 14th Options Now Available For Vertex Pharmaceuticals (VRTX)",
    "published": 1714731420,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 401.5,
      "2024-05-03T14:30:00+00:00": 399.70001220703125,
      "2024-05-03T15:30:00+00:00": 399.93499755859375,
      "2024-05-03T16:30:00+00:00": 400.2200012207031,
      "2024-05-03T17:30:00+00:00": 401.6600036621094,
      "2024-05-03T18:30:00+00:00": 402.04998779296875,
      "2024-05-03T19:30:00+00:00": 402.1099853515625
    },
    "sentiment": 0.9445434212684631
  },
  {
    "title": "Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street\u2019s Radar",
    "published": 1714699320,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 401.5,
      "2024-05-03T14:30:00+00:00": 399.70001220703125,
      "2024-05-03T15:30:00+00:00": 399.93499755859375,
      "2024-05-03T16:30:00+00:00": 400.2200012207031,
      "2024-05-03T17:30:00+00:00": 401.6600036621094,
      "2024-05-03T18:30:00+00:00": 402.04998779296875,
      "2024-05-03T19:30:00+00:00": 402.1099853515625
    },
    "sentiment": 0.87724369764328
  },
  {
    "title": "3 Biotech Stocks to Buy and Hold Through 2030 and Beyond",
    "published": 1714648500,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 402.8550109863281,
      "2024-05-02T14:30:00+00:00": 400.1000061035156,
      "2024-05-02T15:30:00+00:00": 401.68499755859375,
      "2024-05-02T16:30:00+00:00": 403.42999267578125,
      "2024-05-02T17:30:00+00:00": 401.6600036621094,
      "2024-05-02T18:30:00+00:00": 400.69000244140625,
      "2024-05-02T19:30:00+00:00": 400.82501220703125
    },
    "sentiment": 0.8805452585220337
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1714568412,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 392.80999755859375,
      "2024-05-01T14:30:00+00:00": 394.42999267578125,
      "2024-05-01T15:30:00+00:00": 396.4599914550781,
      "2024-05-01T16:30:00+00:00": 397.2650146484375,
      "2024-05-01T17:30:00+00:00": 399.864990234375,
      "2024-05-01T18:30:00+00:00": 401.114990234375,
      "2024-05-01T19:30:00+00:00": 405.135009765625
    },
    "sentiment": 0.9289575219154358
  },
  {
    "title": "Jennifer Schneider Elected to Vertex Board of Directors",
    "published": 1715783400,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 431.0,
      "2024-05-15T14:30:00+00:00": 433.54998779296875,
      "2024-05-15T15:30:00+00:00": 435.5199890136719,
      "2024-05-15T16:30:00+00:00": 436.4421081542969,
      "2024-05-15T17:30:00+00:00": 438.44000244140625,
      "2024-05-15T18:30:00+00:00": 437.32501220703125,
      "2024-05-15T19:30:00+00:00": 437.0350036621094
    },
    "sentiment": 0.9269466996192932
  },
  {
    "title": "Vertex Pharmaceuticals's Options Frenzy: What You Need to Know",
    "published": 1715743980,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 431.0,
      "2024-05-15T14:30:00+00:00": 433.54998779296875,
      "2024-05-15T15:30:00+00:00": 435.5199890136719,
      "2024-05-15T16:30:00+00:00": 436.4421081542969,
      "2024-05-15T17:30:00+00:00": 438.44000244140625,
      "2024-05-15T18:30:00+00:00": 437.32501220703125,
      "2024-05-15T19:30:00+00:00": 437.0350036621094
    },
    "sentiment": 0.9454261064529419
  },
  {
    "title": "3 Cheap Biotech Stocks to Buy Now: May 2024",
    "published": 1715696697,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 428.4525146484375,
      "2024-05-14T14:30:00+00:00": 426.70001220703125,
      "2024-05-14T15:30:00+00:00": 425.1744079589844,
      "2024-05-14T16:30:00+00:00": 423.0050048828125,
      "2024-05-14T17:30:00+00:00": 423.3608093261719,
      "2024-05-14T18:30:00+00:00": 425.7799987792969,
      "2024-05-14T19:30:00+00:00": 427.7099914550781
    },
    "sentiment": 0.9149845838546753
  },
  {
    "title": "Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Comprehensive Guide",
    "published": 1715679240,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 428.4525146484375,
      "2024-05-14T14:30:00+00:00": 426.70001220703125,
      "2024-05-14T15:30:00+00:00": 425.1744079589844,
      "2024-05-14T16:30:00+00:00": 423.0050048828125,
      "2024-05-14T17:30:00+00:00": 423.3608093261719,
      "2024-05-14T18:30:00+00:00": 425.7799987792969,
      "2024-05-14T19:30:00+00:00": 427.7099914550781
    },
    "sentiment": 0.80447918176651
  },
  {
    "title": "Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating",
    "published": 1715659800,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 428.4525146484375,
      "2024-05-14T14:30:00+00:00": 426.70001220703125,
      "2024-05-14T15:30:00+00:00": 425.1744079589844,
      "2024-05-14T16:30:00+00:00": 423.0050048828125,
      "2024-05-14T17:30:00+00:00": 423.3608093261719,
      "2024-05-14T18:30:00+00:00": 425.7799987792969,
      "2024-05-14T19:30:00+00:00": 427.7099914550781
    },
    "sentiment": 0.7267358303070068
  },
  {
    "title": "Vortex Energy Partners for Green Solutions in Newfoundland",
    "published": 1715600220,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 425.989990234375,
      "2024-05-13T14:30:00+00:00": 426.3500061035156,
      "2024-05-13T15:30:00+00:00": 427.07000732421875,
      "2024-05-13T16:30:00+00:00": 427.2049865722656,
      "2024-05-13T17:30:00+00:00": 427.32000732421875,
      "2024-05-13T18:30:00+00:00": 428.20001220703125,
      "2024-05-13T19:30:00+00:00": 429.0400085449219
    },
    "sentiment": 0.7077586650848389
  },
  {
    "title": "2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade",
    "published": 1715530800,
    "day_prices": {},
    "sentiment": 0.893114447593689
  },
  {
    "title": "Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires",
    "published": 1715341800,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 420.3999938964844,
      "2024-05-10T14:30:00+00:00": 419.5,
      "2024-05-10T15:30:00+00:00": 420.8999938964844,
      "2024-05-10T16:30:00+00:00": 420.5299987792969,
      "2024-05-10T17:30:00+00:00": 419.70001220703125,
      "2024-05-10T18:30:00+00:00": 421.7449951171875,
      "2024-05-10T19:30:00+00:00": 422.8999938964844
    },
    "sentiment": 0.4135361313819885
  },
  {
    "title": "CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss",
    "published": 1715266680,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 419.0,
      "2024-05-09T14:30:00+00:00": 417.510009765625,
      "2024-05-09T15:30:00+00:00": 417.0150146484375,
      "2024-05-09T16:30:00+00:00": 417.4849853515625,
      "2024-05-09T17:30:00+00:00": 418.2950134277344,
      "2024-05-09T18:30:00+00:00": 418.7200012207031,
      "2024-05-09T19:30:00+00:00": 420.0
    },
    "sentiment": 0.9562392830848694
  },
  {
    "title": "Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight",
    "published": 1715231091,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 419.0,
      "2024-05-09T14:30:00+00:00": 417.510009765625,
      "2024-05-09T15:30:00+00:00": 417.0150146484375,
      "2024-05-09T16:30:00+00:00": 417.4849853515625,
      "2024-05-09T17:30:00+00:00": 418.2950134277344,
      "2024-05-09T18:30:00+00:00": 418.7200012207031,
      "2024-05-09T19:30:00+00:00": 420.0
    },
    "sentiment": 0.9003154039382935
  },
  {
    "title": "Bluebird bio spikes even as CRISPR leads in gene therapy rollout",
    "published": 1715217240,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 419.0,
      "2024-05-09T14:30:00+00:00": 417.510009765625,
      "2024-05-09T15:30:00+00:00": 417.0150146484375,
      "2024-05-09T16:30:00+00:00": 417.4849853515625,
      "2024-05-09T17:30:00+00:00": 418.2950134277344,
      "2024-05-09T18:30:00+00:00": 418.7200012207031,
      "2024-05-09T19:30:00+00:00": 420.0
    },
    "sentiment": 0.8199981451034546
  },
  {
    "title": "Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations",
    "published": 1715171424,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.9396857023239136
  },
  {
    "title": "Balancing Act: Vertex Pharmaceuticals\u2019 Growth Prospects and Valuation Concerns Justify a Hold Rating",
    "published": 1715161740,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.5277761220932007
  },
  {
    "title": "Unveiling Vertex Pharmaceuticals (VRTX)'s Value: Is It Really Priced Right? A Comprehensive Guide",
    "published": 1715160720,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.8037523627281189
  },
  {
    "title": "Vertex Pharmaceuticals Sell Rating Maintained Amid Unsustainable Performance and Uncertain Pipeline Progress",
    "published": 1715149980,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.9619438052177429
  },
  {
    "title": "A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics",
    "published": 1715133060,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.9067733287811279
  },
  {
    "title": "Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'",
    "published": 1716449580,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 449.8399963378906,
      "2024-05-23T14:30:00+00:00": 449.4649963378906,
      "2024-05-23T15:30:00+00:00": 450.9100036621094,
      "2024-05-23T16:30:00+00:00": 452.70001220703125,
      "2024-05-23T17:30:00+00:00": 451.1499938964844,
      "2024-05-23T18:30:00+00:00": 449.4599914550781,
      "2024-05-23T19:30:00+00:00": 449.8599853515625
    },
    "sentiment": 0.9466620087623596
  },
  {
    "title": "Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity",
    "published": 1716432720,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 449.8399963378906,
      "2024-05-23T14:30:00+00:00": 449.4649963378906,
      "2024-05-23T15:30:00+00:00": 450.9100036621094,
      "2024-05-23T16:30:00+00:00": 452.70001220703125,
      "2024-05-23T17:30:00+00:00": 451.1499938964844,
      "2024-05-23T18:30:00+00:00": 449.4599914550781,
      "2024-05-23T19:30:00+00:00": 449.8599853515625
    },
    "sentiment": 0.7057888507843018
  },
  {
    "title": "Stocks Step Back After Fed Minutes; Loar, Monday.com, VRTX In Focus",
    "published": 1716410452,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 442.5400085449219,
      "2024-05-22T14:30:00+00:00": 445.6499938964844,
      "2024-05-22T15:30:00+00:00": 446.6000061035156,
      "2024-05-22T16:30:00+00:00": 448.1400146484375,
      "2024-05-22T17:30:00+00:00": 449.9100036621094,
      "2024-05-22T18:30:00+00:00": 447.4100036621094,
      "2024-05-22T19:30:00+00:00": 447.2699890136719
    },
    "sentiment": 0.7358055710792542
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "published": 1716349620,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 442.5400085449219,
      "2024-05-22T14:30:00+00:00": 445.6499938964844,
      "2024-05-22T15:30:00+00:00": 446.6000061035156,
      "2024-05-22T16:30:00+00:00": 448.1400146484375,
      "2024-05-22T17:30:00+00:00": 449.9100036621094,
      "2024-05-22T18:30:00+00:00": 447.4100036621094,
      "2024-05-22T19:30:00+00:00": 447.2699890136719
    },
    "sentiment": 0.9419763088226318
  },
  {
    "title": "Is CRISPR Therapeutics Stock a Buy?",
    "published": 1715952600,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 442.0,
      "2024-05-17T14:30:00+00:00": 442.0299987792969,
      "2024-05-17T15:30:00+00:00": 442.2550048828125,
      "2024-05-17T16:30:00+00:00": 442.9549865722656,
      "2024-05-17T17:30:00+00:00": 443.25,
      "2024-05-17T18:30:00+00:00": 444.239990234375,
      "2024-05-17T19:30:00+00:00": 445.75
    },
    "sentiment": 0.9158287048339844
  },
  {
    "title": "How non-opioids could shake up the $75 billion pain-treatment industry",
    "published": 1715828400,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 434.5899963378906,
      "2024-05-16T14:30:00+00:00": 436.19000244140625,
      "2024-05-16T15:30:00+00:00": 436.9700012207031,
      "2024-05-16T16:30:00+00:00": 438.0799865722656,
      "2024-05-16T17:30:00+00:00": 438.2950134277344,
      "2024-05-16T18:30:00+00:00": 438.1099853515625,
      "2024-05-16T19:30:00+00:00": 439.8500061035156
    },
    "sentiment": 0.8330111503601074
  },
  {
    "title": "Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)",
    "published": 1717159500,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 444.739990234375,
      "2024-05-31T14:30:00+00:00": 449.9200134277344,
      "2024-05-31T15:30:00+00:00": 449.4549865722656,
      "2024-05-31T16:30:00+00:00": 449.05999755859375,
      "2024-05-31T17:30:00+00:00": 451.17999267578125,
      "2024-05-31T18:30:00+00:00": 450.94000244140625,
      "2024-05-31T19:30:00+00:00": 453.9200134277344
    },
    "sentiment": 0.9175419211387634
  },
  {
    "title": "Vertex Pharmaceuticals CMO Bozic sells 2,280 common shares",
    "published": 1717125840,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 444.739990234375,
      "2024-05-31T14:30:00+00:00": 449.9200134277344,
      "2024-05-31T15:30:00+00:00": 449.4549865722656,
      "2024-05-31T16:30:00+00:00": 449.05999755859375,
      "2024-05-31T17:30:00+00:00": 451.17999267578125,
      "2024-05-31T18:30:00+00:00": 450.94000244140625,
      "2024-05-31T19:30:00+00:00": 453.9200134277344
    },
    "sentiment": 0.9422603845596313
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1717074011,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 439.1099853515625,
      "2024-05-30T14:30:00+00:00": 439.3399963378906,
      "2024-05-30T15:30:00+00:00": 440.0299987792969,
      "2024-05-30T16:30:00+00:00": 439.822509765625,
      "2024-05-30T17:30:00+00:00": 440.0199890136719,
      "2024-05-30T18:30:00+00:00": 439.9949951171875,
      "2024-05-30T19:30:00+00:00": 441.9159851074219
    },
    "sentiment": 0.9021093249320984
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "published": 1717040580,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 439.1099853515625,
      "2024-05-30T14:30:00+00:00": 439.3399963378906,
      "2024-05-30T15:30:00+00:00": 440.0299987792969,
      "2024-05-30T16:30:00+00:00": 439.822509765625,
      "2024-05-30T17:30:00+00:00": 440.0199890136719,
      "2024-05-30T18:30:00+00:00": 439.9949951171875,
      "2024-05-30T19:30:00+00:00": 441.9159851074219
    },
    "sentiment": 0.9215103983879089
  },
  {
    "title": "Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics",
    "published": 1716891620,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 454.7900085449219,
      "2024-05-28T14:30:00+00:00": 448.4949951171875,
      "2024-05-28T15:30:00+00:00": 450.5400085449219,
      "2024-05-28T16:30:00+00:00": 447.8901062011719,
      "2024-05-28T17:30:00+00:00": 446.989990234375,
      "2024-05-28T18:30:00+00:00": 446.94000244140625,
      "2024-05-28T19:30:00+00:00": 447.04998779296875
    },
    "sentiment": 0.4962400794029236
  },
  {
    "title": "Wells Fargo Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)",
    "published": 1716875220,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 454.7900085449219,
      "2024-05-28T14:30:00+00:00": 448.4949951171875,
      "2024-05-28T15:30:00+00:00": 450.5400085449219,
      "2024-05-28T16:30:00+00:00": 447.8901062011719,
      "2024-05-28T17:30:00+00:00": 446.989990234375,
      "2024-05-28T18:30:00+00:00": 446.94000244140625,
      "2024-05-28T19:30:00+00:00": 447.04998779296875
    },
    "sentiment": 0.9048589468002319
  },
  {
    "title": "3 Underappreciated Biotech Stocks to Buy Now: May 2024",
    "published": 1716819060,
    "day_prices": {},
    "sentiment": 0.7956368923187256
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)",
    "published": 1716795060,
    "day_prices": {},
    "sentiment": 0.9114394783973694
  },
  {
    "title": "Is It Too Late to Buy Vertex Pharmaceuticals Stock?",
    "published": 1716731100,
    "day_prices": {},
    "sentiment": 0.7587010264396667
  },
  {
    "title": "3 High-Flying Stocks That Could Soar Even More",
    "published": 1716634020,
    "day_prices": {},
    "sentiment": 0.5608758330345154
  },
  {
    "title": "2 Superior Growth Stocks to Buy if You Have $1,000 Right Now",
    "published": 1719575100,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 473.2099914550781,
      "2024-06-28T14:30:00+00:00": 475.1099853515625,
      "2024-06-28T15:30:00+00:00": 472.30999755859375,
      "2024-06-28T16:30:00+00:00": 472.8299865722656,
      "2024-06-28T17:30:00+00:00": 475.5799865722656,
      "2024-06-28T18:30:00+00:00": 475.9100036621094,
      "2024-06-28T19:30:00+00:00": 472.42999267578125
    },
    "sentiment": 0.9165011644363403
  },
  {
    "title": "2 Healthcare Stocks That Are Screaming Buys in June",
    "published": 1719559860,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 473.2099914550781,
      "2024-06-28T14:30:00+00:00": 475.1099853515625,
      "2024-06-28T15:30:00+00:00": 472.30999755859375,
      "2024-06-28T16:30:00+00:00": 472.8299865722656,
      "2024-06-28T17:30:00+00:00": 475.5799865722656,
      "2024-06-28T18:30:00+00:00": 475.9100036621094,
      "2024-06-28T19:30:00+00:00": 472.42999267578125
    },
    "sentiment": 0.9331746101379395
  },
  {
    "title": "Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?",
    "published": 1719496440,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 476.7699890136719,
      "2024-06-27T14:30:00+00:00": 476.80999755859375,
      "2024-06-27T15:30:00+00:00": 475.44000244140625,
      "2024-06-27T16:30:00+00:00": 475.2349853515625,
      "2024-06-27T17:30:00+00:00": 474.42999267578125,
      "2024-06-27T18:30:00+00:00": 473.6199951171875,
      "2024-06-27T19:30:00+00:00": 474.1400146484375
    },
    "sentiment": 0.6932816505432129
  },
  {
    "title": "3 Biotech Stocks That Could Make Your Grandchildren Rich",
    "published": 1719484800,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 476.7699890136719,
      "2024-06-27T14:30:00+00:00": 476.80999755859375,
      "2024-06-27T15:30:00+00:00": 475.44000244140625,
      "2024-06-27T16:30:00+00:00": 475.2349853515625,
      "2024-06-27T17:30:00+00:00": 474.42999267578125,
      "2024-06-27T18:30:00+00:00": 473.6199951171875,
      "2024-06-27T19:30:00+00:00": 474.1400146484375
    },
    "sentiment": 0.9181333780288696
  },
  {
    "title": "This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday",
    "published": 1719474180,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 476.7699890136719,
      "2024-06-27T14:30:00+00:00": 476.80999755859375,
      "2024-06-27T15:30:00+00:00": 475.44000244140625,
      "2024-06-27T16:30:00+00:00": 475.2349853515625,
      "2024-06-27T17:30:00+00:00": 474.42999267578125,
      "2024-06-27T18:30:00+00:00": 473.6199951171875,
      "2024-06-27T19:30:00+00:00": 474.1400146484375
    },
    "sentiment": 0.921171247959137
  },
  {
    "title": "Vertex Pharmaceuticals initiated with bullish view at Redburn Atlantic, here's why",
    "published": 1719460740,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 476.7699890136719,
      "2024-06-27T14:30:00+00:00": 476.80999755859375,
      "2024-06-27T15:30:00+00:00": 475.44000244140625,
      "2024-06-27T16:30:00+00:00": 475.2349853515625,
      "2024-06-27T17:30:00+00:00": 474.42999267578125,
      "2024-06-27T18:30:00+00:00": 473.6199951171875,
      "2024-06-27T19:30:00+00:00": 474.1400146484375
    },
    "sentiment": 0.829189658164978
  },
  {
    "title": "Peering Into Vertex Pharmaceuticals's Recent Short Interest",
    "published": 1719372720,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 471.7200012207031,
      "2024-06-26T14:30:00+00:00": 476.45001220703125,
      "2024-06-26T15:30:00+00:00": 475.6700134277344,
      "2024-06-26T16:30:00+00:00": 475.1499938964844,
      "2024-06-26T17:30:00+00:00": 473.8717041015625,
      "2024-06-26T18:30:00+00:00": 473.3699951171875,
      "2024-06-26T19:30:00+00:00": 473.2300109863281
    },
    "sentiment": 0.9329943060874939
  },
  {
    "title": "Jefferies software analyst to hold analyst/industry conference call",
    "published": 1719316200,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 478.29998779296875,
      "2024-06-25T14:30:00+00:00": 474.7799987792969,
      "2024-06-25T15:30:00+00:00": 475.79998779296875,
      "2024-06-25T16:30:00+00:00": 473.8900146484375,
      "2024-06-25T17:30:00+00:00": 472.1099853515625,
      "2024-06-25T18:30:00+00:00": 473.29998779296875,
      "2024-06-25T19:30:00+00:00": 472.58050537109375
    },
    "sentiment": 0.9412994980812073
  },
  {
    "title": "Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?",
    "published": 1719303120,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 478.29998779296875,
      "2024-06-25T14:30:00+00:00": 474.7799987792969,
      "2024-06-25T15:30:00+00:00": 475.79998779296875,
      "2024-06-25T16:30:00+00:00": 473.8900146484375,
      "2024-06-25T17:30:00+00:00": 472.1099853515625,
      "2024-06-25T18:30:00+00:00": 473.29998779296875,
      "2024-06-25T19:30:00+00:00": 472.58050537109375
    },
    "sentiment": 0.9235875606536865
  },
  {
    "title": "Maintaining Hold on Vertex Pharmaceuticals Amid Promising Yet Early VX-880 Data and Premium Valuation Concerns",
    "published": 1719284160,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 478.29998779296875,
      "2024-06-25T14:30:00+00:00": 474.7799987792969,
      "2024-06-25T15:30:00+00:00": 475.79998779296875,
      "2024-06-25T16:30:00+00:00": 473.8900146484375,
      "2024-06-25T17:30:00+00:00": 472.1099853515625,
      "2024-06-25T18:30:00+00:00": 473.29998779296875,
      "2024-06-25T19:30:00+00:00": 472.58050537109375
    },
    "sentiment": 0.7615759372711182
  },
  {
    "title": "Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock\u2019s Strong Financial Performance in Q1",
    "published": 1719238308,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 472.7200012207031,
      "2024-06-24T14:30:00+00:00": 468.8699951171875,
      "2024-06-24T15:30:00+00:00": 470.5950012207031,
      "2024-06-24T16:30:00+00:00": 475.1549987792969,
      "2024-06-24T17:30:00+00:00": 475.760009765625,
      "2024-06-24T18:30:00+00:00": 476.75,
      "2024-06-24T19:30:00+00:00": 475.25
    },
    "sentiment": 0.9336379170417786
  },
  {
    "title": "Vortex Energy Begins Key Drilling Project",
    "published": 1719227940,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 472.7200012207031,
      "2024-06-24T14:30:00+00:00": 468.8699951171875,
      "2024-06-24T15:30:00+00:00": 470.5950012207031,
      "2024-06-24T16:30:00+00:00": 475.1549987792969,
      "2024-06-24T17:30:00+00:00": 475.760009765625,
      "2024-06-24T18:30:00+00:00": 476.75,
      "2024-06-24T19:30:00+00:00": 475.25
    },
    "sentiment": 0.7773633003234863
  },
  {
    "title": "Vortex Energy Announces Commencement of Drilling at the Robinsons River Salt Project",
    "published": 1719216000,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 472.7200012207031,
      "2024-06-24T14:30:00+00:00": 468.8699951171875,
      "2024-06-24T15:30:00+00:00": 470.5950012207031,
      "2024-06-24T16:30:00+00:00": 475.1549987792969,
      "2024-06-24T17:30:00+00:00": 475.760009765625,
      "2024-06-24T18:30:00+00:00": 476.75,
      "2024-06-24T19:30:00+00:00": 475.25
    },
    "sentiment": 0.8742786049842834
  },
  {
    "title": "Vertex Pharmaceuticals\u2019 Promising T1D Therapy and Diversified Pipeline Merit a Buy Rating",
    "published": 1719206400,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 472.7200012207031,
      "2024-06-24T14:30:00+00:00": 468.8699951171875,
      "2024-06-24T15:30:00+00:00": 470.5950012207031,
      "2024-06-24T16:30:00+00:00": 475.1549987792969,
      "2024-06-24T17:30:00+00:00": 475.760009765625,
      "2024-06-24T18:30:00+00:00": 476.75,
      "2024-06-24T19:30:00+00:00": 475.25
    },
    "sentiment": 0.9444254636764526
  },
  {
    "title": "Vertex Pharmaceuticals\u2019 VX-880 Shows Promising Durability and Efficacy in T1D Therapy, Merits Buy Rating",
    "published": 1719047160,
    "day_prices": {},
    "sentiment": 0.9061174392700195
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Vertex Pharmaceuticals (VRTX)",
    "published": 1719046260,
    "day_prices": {},
    "sentiment": 0.9126845598220825
  },
  {
    "title": "Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions",
    "published": 1718999100,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 464.6400146484375,
      "2024-06-21T14:30:00+00:00": 469.69000244140625,
      "2024-06-21T15:30:00+00:00": 466.67999267578125,
      "2024-06-21T16:30:00+00:00": 466.0299987792969,
      "2024-06-21T17:30:00+00:00": 467.3500061035156,
      "2024-06-21T18:30:00+00:00": 468.6000061035156,
      "2024-06-21T19:30:00+00:00": 469.22198486328125
    },
    "sentiment": 0.8563150763511658
  },
  {
    "title": "Reshma Kewalramani Is Guiding Vertex Pharmaceuticals to Its Next Big Thing",
    "published": 1718985600,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 464.6400146484375,
      "2024-06-21T14:30:00+00:00": 469.69000244140625,
      "2024-06-21T15:30:00+00:00": 466.67999267578125,
      "2024-06-21T16:30:00+00:00": 466.0299987792969,
      "2024-06-21T17:30:00+00:00": 467.3500061035156,
      "2024-06-21T18:30:00+00:00": 468.6000061035156,
      "2024-06-21T19:30:00+00:00": 469.22198486328125
    },
    "sentiment": 0.5231733322143555
  },
  {
    "title": "Vertex releases positive phase 1/2 results on VX-880 for type 1 diabetes",
    "published": 1718942040,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 464.6400146484375,
      "2024-06-21T14:30:00+00:00": 469.69000244140625,
      "2024-06-21T15:30:00+00:00": 466.67999267578125,
      "2024-06-21T16:30:00+00:00": 466.0299987792969,
      "2024-06-21T17:30:00+00:00": 467.3500061035156,
      "2024-06-21T18:30:00+00:00": 468.6000061035156,
      "2024-06-21T19:30:00+00:00": 469.22198486328125
    },
    "sentiment": 0.9327454566955566
  },
  {
    "title": "Vertex Announces Extended Long-Term Reimbursement Agreement with NHS England for Access to Cystic Fibrosis Medicines KAFTRIO\u00ae, SYMKEVI\u00ae and ORKAMBI\u00ae",
    "published": 1718867766,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 466.0,
      "2024-06-20T14:30:00+00:00": 467.6050109863281,
      "2024-06-20T15:30:00+00:00": 467.4849853515625,
      "2024-06-20T16:30:00+00:00": 467.8699951171875,
      "2024-06-20T17:30:00+00:00": 470.5899963378906,
      "2024-06-20T18:30:00+00:00": 472.125,
      "2024-06-20T19:30:00+00:00": 471.44500732421875
    },
    "sentiment": 0.94631028175354
  },
  {
    "title": "Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?",
    "published": 1718803561,
    "day_prices": {},
    "sentiment": 0.7834300398826599
  },
  {
    "title": "Vertex: New, Longer-Term Casgevy Data Makes Case For Blockbuster Sales",
    "published": 1718630451,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 479.1300048828125,
      "2024-06-17T14:30:00+00:00": 476.68499755859375,
      "2024-06-17T15:30:00+00:00": 478.41009521484375,
      "2024-06-17T16:30:00+00:00": 476.6600036621094,
      "2024-06-17T17:30:00+00:00": 476.8399963378906,
      "2024-06-17T18:30:00+00:00": 476.4200134277344,
      "2024-06-17T19:30:00+00:00": 475.79998779296875
    },
    "sentiment": 0.8278093934059143
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $85 at Argus, here's why",
    "published": 1718611080,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 479.1300048828125,
      "2024-06-17T14:30:00+00:00": 476.68499755859375,
      "2024-06-17T15:30:00+00:00": 478.41009521484375,
      "2024-06-17T16:30:00+00:00": 476.6600036621094,
      "2024-06-17T17:30:00+00:00": 476.8399963378906,
      "2024-06-17T18:30:00+00:00": 476.4200134277344,
      "2024-06-17T19:30:00+00:00": 475.79998779296875
    },
    "sentiment": 0.7666093707084656
  },
  {
    "title": "Entrada Therapeutics: A Complicated Tale",
    "published": 1718536516,
    "day_prices": {},
    "sentiment": 0.9234256148338318
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?",
    "published": 1718406290,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 477.7300109863281,
      "2024-06-14T14:30:00+00:00": 480.5400085449219,
      "2024-06-14T15:30:00+00:00": 480.625,
      "2024-06-14T16:30:00+00:00": 481.8800048828125,
      "2024-06-14T17:30:00+00:00": 482.8399963378906,
      "2024-06-14T18:30:00+00:00": 481.3349914550781,
      "2024-06-14T19:30:00+00:00": 482.2300109863281
    },
    "sentiment": 0.6153150200843811
  },
  {
    "title": "Vertex Presents Positive Long-Term Data On CASGEVY\u2122 (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress",
    "published": 1718348580,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 477.7300109863281,
      "2024-06-14T14:30:00+00:00": 480.5400085449219,
      "2024-06-14T15:30:00+00:00": 480.625,
      "2024-06-14T16:30:00+00:00": 481.8800048828125,
      "2024-06-14T17:30:00+00:00": 482.8399963378906,
      "2024-06-14T18:30:00+00:00": 481.3349914550781,
      "2024-06-14T19:30:00+00:00": 482.2300109863281
    },
    "sentiment": 0.9256365299224854
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX) and R1 RCM (RCM)",
    "published": 1718330580,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 477.7300109863281,
      "2024-06-14T14:30:00+00:00": 480.5400085449219,
      "2024-06-14T15:30:00+00:00": 480.625,
      "2024-06-14T16:30:00+00:00": 481.8800048828125,
      "2024-06-14T17:30:00+00:00": 482.8399963378906,
      "2024-06-14T18:30:00+00:00": 481.3349914550781,
      "2024-06-14T19:30:00+00:00": 482.2300109863281
    },
    "sentiment": 0.8102369904518127
  },
  {
    "title": "August 2nd Options Now Available For Vertex Pharmaceuticals (VRTX)",
    "published": 1718272320,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 473.5,
      "2024-06-13T14:30:00+00:00": 480.5,
      "2024-06-13T15:30:00+00:00": 480.2200012207031,
      "2024-06-13T16:30:00+00:00": 479.43499755859375,
      "2024-06-13T17:30:00+00:00": 479.401611328125,
      "2024-06-13T18:30:00+00:00": 478.75,
      "2024-06-13T19:30:00+00:00": 478.4100036621094
    },
    "sentiment": 0.9501985907554626
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Declines While Market Improves: Some Information for Investors",
    "published": 1718229009,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 478.0,
      "2024-06-12T14:30:00+00:00": 479.260009765625,
      "2024-06-12T15:30:00+00:00": 477.8299865722656,
      "2024-06-12T16:30:00+00:00": 475.8900146484375,
      "2024-06-12T17:30:00+00:00": 477.4800109863281,
      "2024-06-12T18:30:00+00:00": 476.135009765625,
      "2024-06-12T19:30:00+00:00": 473.82000732421875
    },
    "sentiment": 0.5953786373138428
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)",
    "published": 1718122930,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 480.0,
      "2024-06-11T14:30:00+00:00": 478.75,
      "2024-06-11T15:30:00+00:00": 479.989990234375,
      "2024-06-11T16:30:00+00:00": 481.44500732421875,
      "2024-06-11T17:30:00+00:00": 481.17999267578125,
      "2024-06-11T18:30:00+00:00": 482.2950134277344,
      "2024-06-11T19:30:00+00:00": 482.1499938964844
    },
    "sentiment": 0.9322854280471802
  },
  {
    "title": "Vertex Pharmaceuticals price target lowered by $3 at RBC Capital, here's why",
    "published": 1718093820,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 480.0,
      "2024-06-11T14:30:00+00:00": 478.75,
      "2024-06-11T15:30:00+00:00": 479.989990234375,
      "2024-06-11T16:30:00+00:00": 481.44500732421875,
      "2024-06-11T17:30:00+00:00": 481.17999267578125,
      "2024-06-11T18:30:00+00:00": 482.2950134277344,
      "2024-06-11T19:30:00+00:00": 482.1499938964844
    },
    "sentiment": 0.7893196940422058
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Receives a Hold from RBC Capital",
    "published": 1718085360,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 480.0,
      "2024-06-11T14:30:00+00:00": 478.75,
      "2024-06-11T15:30:00+00:00": 479.989990234375,
      "2024-06-11T16:30:00+00:00": 481.44500732421875,
      "2024-06-11T17:30:00+00:00": 481.17999267578125,
      "2024-06-11T18:30:00+00:00": 482.2950134277344,
      "2024-06-11T19:30:00+00:00": 482.1499938964844
    },
    "sentiment": 0.8737096786499023
  },
  {
    "title": "Vertex Pharmaceuticals Says Phase 3 Data Show Trikafta Improves Lung Function in Cystic Fibrosis Patients",
    "published": 1717780966,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 484.45001220703125,
      "2024-06-07T14:30:00+00:00": 484.54998779296875,
      "2024-06-07T15:30:00+00:00": 484.30499267578125,
      "2024-06-07T16:30:00+00:00": 484.29998779296875,
      "2024-06-07T17:30:00+00:00": 485.07000732421875,
      "2024-06-07T18:30:00+00:00": 484.05999755859375,
      "2024-06-07T19:30:00+00:00": 484.2900085449219
    },
    "sentiment": 0.9502526521682739
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) The 44th Annual William Blair Growth Stock Conference",
    "published": 1717764963,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 484.45001220703125,
      "2024-06-07T14:30:00+00:00": 484.54998779296875,
      "2024-06-07T15:30:00+00:00": 484.30499267578125,
      "2024-06-07T16:30:00+00:00": 484.29998779296875,
      "2024-06-07T17:30:00+00:00": 485.07000732421875,
      "2024-06-07T18:30:00+00:00": 484.05999755859375,
      "2024-06-07T19:30:00+00:00": 484.2900085449219
    },
    "sentiment": 0.9360048174858093
  },
  {
    "title": "Buy Rating Affirmed for Vertex Pharmaceuticals on Strong CF Market Presence and Promising Pipeline",
    "published": 1717556760,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 475.260009765625,
      "2024-06-05T14:30:00+00:00": 477.1400146484375,
      "2024-06-05T15:30:00+00:00": 480.5199890136719,
      "2024-06-05T16:30:00+00:00": 482.1499938964844,
      "2024-06-05T17:30:00+00:00": 482.8949890136719,
      "2024-06-05T18:30:00+00:00": 482.0950012207031,
      "2024-06-05T19:30:00+00:00": 482.9800109863281
    },
    "sentiment": 0.9545215964317322
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated : 2024 VRTX William Blair Growth Stock Conference Presentation vFinal",
    "published": 1717523346,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 472.57000732421875,
      "2024-06-04T14:30:00+00:00": 470.0,
      "2024-06-04T15:30:00+00:00": 469.6199951171875,
      "2024-06-04T16:30:00+00:00": 468.32000732421875,
      "2024-06-04T17:30:00+00:00": 470.6050109863281,
      "2024-06-04T18:30:00+00:00": 474.9200134277344,
      "2024-06-04T19:30:00+00:00": 474.69000244140625
    },
    "sentiment": 0.9471473097801208
  },
  {
    "title": "Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP, Chief Regulatory & Quality ...",
    "published": 1717504740,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 472.57000732421875,
      "2024-06-04T14:30:00+00:00": 470.0,
      "2024-06-04T15:30:00+00:00": 469.6199951171875,
      "2024-06-04T16:30:00+00:00": 468.32000732421875,
      "2024-06-04T17:30:00+00:00": 470.6050109863281,
      "2024-06-04T18:30:00+00:00": 474.9200134277344,
      "2024-06-04T19:30:00+00:00": 474.69000244140625
    },
    "sentiment": 0.6409008502960205
  },
  {
    "title": "RBC Capital Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX)",
    "published": 1717484820,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 472.57000732421875,
      "2024-06-04T14:30:00+00:00": 470.0,
      "2024-06-04T15:30:00+00:00": 469.6199951171875,
      "2024-06-04T16:30:00+00:00": 468.32000732421875,
      "2024-06-04T17:30:00+00:00": 470.6050109863281,
      "2024-06-04T18:30:00+00:00": 474.9200134277344,
      "2024-06-04T19:30:00+00:00": 474.69000244140625
    },
    "sentiment": 0.7001847624778748
  },
  {
    "title": "Crispr Therapeutics' Strategic Moves Amidst Gene Therapy Challenges (Rating Upgrade)",
    "published": 1717418460,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 454.9800109863281,
      "2024-06-03T14:30:00+00:00": 465.26849365234375,
      "2024-06-03T15:30:00+00:00": 470.9150085449219,
      "2024-06-03T16:30:00+00:00": 467.25,
      "2024-06-03T17:30:00+00:00": 464.9200134277344,
      "2024-06-03T18:30:00+00:00": 466.8450012207031,
      "2024-06-03T19:30:00+00:00": 467.989990234375
    },
    "sentiment": 0.5400241017341614
  },
  {
    "title": "This Is What Whales Are Betting On Vertex Pharmaceuticals",
    "published": 1717381320,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 454.9800109863281,
      "2024-06-03T14:30:00+00:00": 465.26849365234375,
      "2024-06-03T15:30:00+00:00": 470.9150085449219,
      "2024-06-03T16:30:00+00:00": 467.25,
      "2024-06-03T17:30:00+00:00": 464.9200134277344,
      "2024-06-03T18:30:00+00:00": 466.8450012207031,
      "2024-06-03T19:30:00+00:00": 467.989990234375
    },
    "sentiment": 0.9009178280830383
  },
  {
    "title": "14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know",
    "published": 1722416520,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 507.0400085449219,
      "2024-07-31T14:30:00+00:00": 502.4800109863281,
      "2024-07-31T15:30:00+00:00": 503.5,
      "2024-07-31T16:30:00+00:00": 501.8949890136719,
      "2024-07-31T17:30:00+00:00": 503.44000244140625,
      "2024-07-31T18:30:00+00:00": 499.20001220703125,
      "2024-07-31T19:30:00+00:00": 497.75
    },
    "sentiment": 0.9406828284263611
  },
  {
    "title": "Vertex Pharmaceuticals Q2 2024 Earnings Preview",
    "published": 1722399960,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 507.0400085449219,
      "2024-07-31T14:30:00+00:00": 502.4800109863281,
      "2024-07-31T15:30:00+00:00": 503.5,
      "2024-07-31T16:30:00+00:00": 501.8949890136719,
      "2024-07-31T17:30:00+00:00": 503.44000244140625,
      "2024-07-31T18:30:00+00:00": 499.20001220703125,
      "2024-07-31T19:30:00+00:00": 497.75
    },
    "sentiment": 0.898004949092865
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-To-Severe Acute Pain",
    "published": 1722345000,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 499.70001220703125,
      "2024-07-30T14:30:00+00:00": 503.0,
      "2024-07-30T15:30:00+00:00": 501.8500061035156,
      "2024-07-30T16:30:00+00:00": 501.94000244140625,
      "2024-07-30T17:30:00+00:00": 500.5249938964844,
      "2024-07-30T18:30:00+00:00": 501.8599853515625,
      "2024-07-30T19:30:00+00:00": 501.8699951171875
    },
    "sentiment": 0.9047343134880066
  },
  {
    "title": "Vertex NDA for suzetrigine for acute pain accepted by FDA",
    "published": 1722342780,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 499.70001220703125,
      "2024-07-30T14:30:00+00:00": 503.0,
      "2024-07-30T15:30:00+00:00": 501.8500061035156,
      "2024-07-30T16:30:00+00:00": 501.94000244140625,
      "2024-07-30T17:30:00+00:00": 500.5249938964844,
      "2024-07-30T18:30:00+00:00": 501.8599853515625,
      "2024-07-30T19:30:00+00:00": 501.8699951171875
    },
    "sentiment": 0.7098694443702698
  },
  {
    "title": "PepGen stock tumbles 25% following release of DMD drug data",
    "published": 1722321840,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 499.70001220703125,
      "2024-07-30T14:30:00+00:00": 503.0,
      "2024-07-30T15:30:00+00:00": 501.8500061035156,
      "2024-07-30T16:30:00+00:00": 501.94000244140625,
      "2024-07-30T17:30:00+00:00": 500.5249938964844,
      "2024-07-30T18:30:00+00:00": 501.8599853515625,
      "2024-07-30T19:30:00+00:00": 501.8699951171875
    },
    "sentiment": 0.9665219187736511
  },
  {
    "title": "Curious about Vertex (VRTX) Q2 Performance? Explore Wall Street Estimates for Key Metrics",
    "published": 1722258973,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 495.260009765625,
      "2024-07-29T14:30:00+00:00": 499.79998779296875,
      "2024-07-29T15:30:00+00:00": 498.5849914550781,
      "2024-07-29T16:30:00+00:00": 500.7099914550781,
      "2024-07-29T17:30:00+00:00": 500.4599914550781,
      "2024-07-29T18:30:00+00:00": 496.6400146484375,
      "2024-07-29T19:30:00+00:00": 498.3699951171875
    },
    "sentiment": 0.915692925453186
  },
  {
    "title": "2 No-Brainer Growth Stocks to Buy With $1,000 Right Now",
    "published": 1722156060,
    "day_prices": {},
    "sentiment": 0.9123209714889526
  },
  {
    "title": "Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release",
    "published": 1722002431,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 493.1400146484375,
      "2024-07-26T14:30:00+00:00": 499.2200012207031,
      "2024-07-26T15:30:00+00:00": 502.0,
      "2024-07-26T16:30:00+00:00": 500.57269287109375,
      "2024-07-26T17:30:00+00:00": 499.2200012207031,
      "2024-07-26T18:30:00+00:00": 496.4599914550781,
      "2024-07-26T19:30:00+00:00": 496.8599853515625
    },
    "sentiment": 0.5789631009101868
  },
  {
    "title": "Needham Remains a Hold on Vertex Pharmaceuticals (VRTX)",
    "published": 1721979420,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 493.1400146484375,
      "2024-07-26T14:30:00+00:00": 499.2200012207031,
      "2024-07-26T15:30:00+00:00": 502.0,
      "2024-07-26T16:30:00+00:00": 500.57269287109375,
      "2024-07-26T17:30:00+00:00": 499.2200012207031,
      "2024-07-26T18:30:00+00:00": 496.4599914550781,
      "2024-07-26T19:30:00+00:00": 496.8599853515625
    },
    "sentiment": 0.8774193525314331
  },
  {
    "title": "Actinium wins FDA nod to conduct clinical trial for radiotherapy",
    "published": 1721900160,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 494.0,
      "2024-07-25T14:30:00+00:00": 502.5,
      "2024-07-25T15:30:00+00:00": 492.8399963378906,
      "2024-07-25T16:30:00+00:00": 495.9750061035156,
      "2024-07-25T17:30:00+00:00": 495.57501220703125,
      "2024-07-25T18:30:00+00:00": 492.5299987792969,
      "2024-07-25T19:30:00+00:00": 493.8900146484375
    },
    "sentiment": 0.8815838694572449
  },
  {
    "title": "Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...",
    "published": 1721862074,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 486.5,
      "2024-07-24T14:30:00+00:00": 489.3949890136719,
      "2024-07-24T15:30:00+00:00": 487.57000732421875,
      "2024-07-24T16:30:00+00:00": 490.5,
      "2024-07-24T17:30:00+00:00": 490.6600036621094,
      "2024-07-24T18:30:00+00:00": 490.45001220703125,
      "2024-07-24T19:30:00+00:00": 491.1000061035156
    },
    "sentiment": 0.9222253561019897
  },
  {
    "title": "Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock",
    "published": 1721826010,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 486.5,
      "2024-07-24T14:30:00+00:00": 489.3949890136719,
      "2024-07-24T15:30:00+00:00": 487.57000732421875,
      "2024-07-24T16:30:00+00:00": 490.5,
      "2024-07-24T17:30:00+00:00": 490.6600036621094,
      "2024-07-24T18:30:00+00:00": 490.45001220703125,
      "2024-07-24T19:30:00+00:00": 491.1000061035156
    },
    "sentiment": 0.9179341197013855
  },
  {
    "title": "Pipeline power: Sionna\u2019s AbbVie deal could redefine CF therapeutics",
    "published": 1721807535,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 486.5,
      "2024-07-24T14:30:00+00:00": 489.3949890136719,
      "2024-07-24T15:30:00+00:00": 487.57000732421875,
      "2024-07-24T16:30:00+00:00": 490.5,
      "2024-07-24T17:30:00+00:00": 490.6600036621094,
      "2024-07-24T18:30:00+00:00": 490.45001220703125,
      "2024-07-24T19:30:00+00:00": 491.1000061035156
    },
    "sentiment": 0.6252462863922119
  },
  {
    "title": "HHS gives thumbs down to bluebird\u2019s fertility support programme",
    "published": 1721757258,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 494.69000244140625,
      "2024-07-23T14:30:00+00:00": 490.5450134277344,
      "2024-07-23T15:30:00+00:00": 491.1099853515625,
      "2024-07-23T16:30:00+00:00": 492.0,
      "2024-07-23T17:30:00+00:00": 492.0299987792969,
      "2024-07-23T18:30:00+00:00": 494.2366027832031,
      "2024-07-23T19:30:00+00:00": 493.5400085449219
    },
    "sentiment": 0.5337944626808167
  },
  {
    "title": "Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today",
    "published": 1721727420,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 494.69000244140625,
      "2024-07-23T14:30:00+00:00": 490.5450134277344,
      "2024-07-23T15:30:00+00:00": 491.1099853515625,
      "2024-07-23T16:30:00+00:00": 492.0,
      "2024-07-23T17:30:00+00:00": 492.0299987792969,
      "2024-07-23T18:30:00+00:00": 494.2366027832031,
      "2024-07-23T19:30:00+00:00": 493.5400085449219
    },
    "sentiment": 0.9414618611335754
  },
  {
    "title": "Piper Sandler Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)",
    "published": 1721713260,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 494.69000244140625,
      "2024-07-23T14:30:00+00:00": 490.5450134277344,
      "2024-07-23T15:30:00+00:00": 491.1099853515625,
      "2024-07-23T16:30:00+00:00": 492.0,
      "2024-07-23T17:30:00+00:00": 492.0299987792969,
      "2024-07-23T18:30:00+00:00": 494.2366027832031,
      "2024-07-23T19:30:00+00:00": 493.5400085449219
    },
    "sentiment": 0.8110734820365906
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)",
    "published": 1721707320,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 494.69000244140625,
      "2024-07-23T14:30:00+00:00": 490.5450134277344,
      "2024-07-23T15:30:00+00:00": 491.1099853515625,
      "2024-07-23T16:30:00+00:00": 492.0,
      "2024-07-23T17:30:00+00:00": 492.0299987792969,
      "2024-07-23T18:30:00+00:00": 494.2366027832031,
      "2024-07-23T19:30:00+00:00": 493.5400085449219
    },
    "sentiment": 0.7335154414176941
  },
  {
    "title": "3 Gene Editing Stocks Shaping the Future of Medicine",
    "published": 1721681100,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 497.0,
      "2024-07-22T14:30:00+00:00": 496.4100036621094,
      "2024-07-22T15:30:00+00:00": 492.0,
      "2024-07-22T16:30:00+00:00": 492.67999267578125,
      "2024-07-22T17:30:00+00:00": 494.6700134277344,
      "2024-07-22T18:30:00+00:00": 495.92999267578125,
      "2024-07-22T19:30:00+00:00": 494.9700012207031
    },
    "sentiment": 0.8735917210578918
  },
  {
    "title": "Strong Buy Rating for Vertex Pharmaceuticals as Casgevy Shows Promise in Sickle Cell Treatment Landscape",
    "published": 1721366220,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 490.7300109863281,
      "2024-07-19T14:30:00+00:00": 492.2250061035156,
      "2024-07-19T15:30:00+00:00": 491.6098937988281,
      "2024-07-19T16:30:00+00:00": 492.44000244140625,
      "2024-07-19T17:30:00+00:00": 489.614990234375,
      "2024-07-19T18:30:00+00:00": 490.4100036621094,
      "2024-07-19T19:30:00+00:00": 491.75
    },
    "sentiment": 0.9543628692626953
  },
  {
    "title": "3 Gene Editing Stocks That Could Grow Your Wealth",
    "published": 1721237434,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 489.95001220703125,
      "2024-07-17T14:30:00+00:00": 486.760009765625,
      "2024-07-17T15:30:00+00:00": 479.1050109863281,
      "2024-07-17T16:30:00+00:00": 483.260009765625,
      "2024-07-17T17:30:00+00:00": 487.04998779296875,
      "2024-07-17T18:30:00+00:00": 489.489990234375,
      "2024-07-17T19:30:00+00:00": 488.3349914550781
    },
    "sentiment": 0.8814127445220947
  },
  {
    "title": "Vertex taps Orum to hunt for better \u2018preconditioning\u2019 drugs",
    "published": 1721131200,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 493.25,
      "2024-07-16T14:30:00+00:00": 493.7799987792969,
      "2024-07-16T15:30:00+00:00": 493.70001220703125,
      "2024-07-16T16:30:00+00:00": 490.0199890136719,
      "2024-07-16T17:30:00+00:00": 489.0799865722656,
      "2024-07-16T18:30:00+00:00": 489.7099914550781,
      "2024-07-16T19:30:00+00:00": 489.2799987792969
    },
    "sentiment": 0.7451160550117493
  },
  {
    "title": "Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?",
    "published": 1721117700,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 493.25,
      "2024-07-16T14:30:00+00:00": 493.7799987792969,
      "2024-07-16T15:30:00+00:00": 493.70001220703125,
      "2024-07-16T16:30:00+00:00": 490.0199890136719,
      "2024-07-16T17:30:00+00:00": 489.0799865722656,
      "2024-07-16T18:30:00+00:00": 489.7099914550781,
      "2024-07-16T19:30:00+00:00": 489.2799987792969
    },
    "sentiment": 0.9004549980163574
  },
  {
    "title": "Vertex Pharmaceuticals expands drug discovery collaboration with Genomics",
    "published": 1721095620,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 493.25,
      "2024-07-16T14:30:00+00:00": 493.7799987792969,
      "2024-07-16T15:30:00+00:00": 493.70001220703125,
      "2024-07-16T16:30:00+00:00": 490.0199890136719,
      "2024-07-16T17:30:00+00:00": 489.0799865722656,
      "2024-07-16T18:30:00+00:00": 489.7099914550781,
      "2024-07-16T19:30:00+00:00": 489.2799987792969
    },
    "sentiment": 0.8780173063278198
  },
  {
    "title": "Vertex Sues U.S. to Pay for Fertility Treatments",
    "published": 1721063192,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 488.0,
      "2024-07-15T14:30:00+00:00": 490.44000244140625,
      "2024-07-15T15:30:00+00:00": 492.80499267578125,
      "2024-07-15T16:30:00+00:00": 493.0400085449219,
      "2024-07-15T17:30:00+00:00": 493.0,
      "2024-07-15T18:30:00+00:00": 492.2799987792969,
      "2024-07-15T19:30:00+00:00": 493.6000061035156
    },
    "sentiment": 0.7751674652099609
  },
  {
    "title": "Health Canada Grants Marketing Authorization for TRIKAFTA\u00ae (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations",
    "published": 1721048400,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 488.0,
      "2024-07-15T14:30:00+00:00": 490.44000244140625,
      "2024-07-15T15:30:00+00:00": 492.80499267578125,
      "2024-07-15T16:30:00+00:00": 493.0400085449219,
      "2024-07-15T17:30:00+00:00": 493.0,
      "2024-07-15T18:30:00+00:00": 492.2799987792969,
      "2024-07-15T19:30:00+00:00": 493.6000061035156
    },
    "sentiment": 0.5992917418479919
  },
  {
    "title": "Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split",
    "published": 1721031300,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 488.0,
      "2024-07-15T14:30:00+00:00": 490.44000244140625,
      "2024-07-15T15:30:00+00:00": 492.80499267578125,
      "2024-07-15T16:30:00+00:00": 493.0400085449219,
      "2024-07-15T17:30:00+00:00": 493.0,
      "2024-07-15T18:30:00+00:00": 492.2799987792969,
      "2024-07-15T19:30:00+00:00": 493.6000061035156
    },
    "sentiment": 0.8922989964485168
  },
  {
    "title": "Crispr Therapeutics Remains Expensive, With Slower Casgevy Monetization And Patent Battle",
    "published": 1720864800,
    "day_prices": {},
    "sentiment": 0.49101579189300537
  },
  {
    "title": "1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid",
    "published": 1720701900,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 491.3299865722656,
      "2024-07-11T14:30:00+00:00": 490.7674865722656,
      "2024-07-11T15:30:00+00:00": 491.4599914550781,
      "2024-07-11T16:30:00+00:00": 493.3599853515625,
      "2024-07-11T17:30:00+00:00": 493.5299987792969,
      "2024-07-11T18:30:00+00:00": 491.79998779296875,
      "2024-07-11T19:30:00+00:00": 491.32000732421875
    },
    "sentiment": 0.9317986965179443
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know",
    "published": 1720562420,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 485.0,
      "2024-07-09T14:30:00+00:00": 484.5,
      "2024-07-09T15:30:00+00:00": 486.20001220703125,
      "2024-07-09T16:30:00+00:00": 486.0299987792969,
      "2024-07-09T17:30:00+00:00": 486.7699890136719,
      "2024-07-09T18:30:00+00:00": 486.1449890136719,
      "2024-07-09T19:30:00+00:00": 485.54998779296875
    },
    "sentiment": 0.7945610284805298
  },
  {
    "title": "The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024",
    "published": 1720522800,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 485.0,
      "2024-07-09T14:30:00+00:00": 484.5,
      "2024-07-09T15:30:00+00:00": 486.20001220703125,
      "2024-07-09T16:30:00+00:00": 486.0299987792969,
      "2024-07-09T17:30:00+00:00": 486.7699890136719,
      "2024-07-09T18:30:00+00:00": 486.1449890136719,
      "2024-07-09T19:30:00+00:00": 485.54998779296875
    },
    "sentiment": 0.7962020635604858
  },
  {
    "title": "3 No-Brainer Stocks to Buy in July",
    "published": 1720440000,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 473.0,
      "2024-07-08T14:30:00+00:00": 478.42010498046875,
      "2024-07-08T15:30:00+00:00": 479.4100036621094,
      "2024-07-08T16:30:00+00:00": 480.1499938964844,
      "2024-07-08T17:30:00+00:00": 481.8299865722656,
      "2024-07-08T18:30:00+00:00": 482.489990234375,
      "2024-07-08T19:30:00+00:00": 482.2300109863281
    },
    "sentiment": 0.8826214075088501
  },
  {
    "title": "Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).",
    "published": 1720253700,
    "day_prices": {},
    "sentiment": 0.8425475358963013
  },
  {
    "title": "The 3 Best Biotech Stocks to Buy in July 2024",
    "published": 1720203296,
    "day_prices": {
      "2024-07-05T13:30:00+00:00": 473.6099853515625,
      "2024-07-05T14:30:00+00:00": 473.6400146484375,
      "2024-07-05T15:30:00+00:00": 474.8399963378906,
      "2024-07-05T16:30:00+00:00": 474.7200012207031,
      "2024-07-05T17:30:00+00:00": 475.4100036621094,
      "2024-07-05T18:30:00+00:00": 474.64300537109375,
      "2024-07-05T19:30:00+00:00": 473.4100036621094
    },
    "sentiment": 0.8355516791343689
  },
  {
    "title": "Did Vertex Pharmaceuticals Just Invent the Next Ozempic?",
    "published": 1720172700,
    "day_prices": {
      "2024-07-05T13:30:00+00:00": 473.6099853515625,
      "2024-07-05T14:30:00+00:00": 473.6400146484375,
      "2024-07-05T15:30:00+00:00": 474.8399963378906,
      "2024-07-05T16:30:00+00:00": 474.7200012207031,
      "2024-07-05T17:30:00+00:00": 475.4100036621094,
      "2024-07-05T18:30:00+00:00": 474.64300537109375,
      "2024-07-05T19:30:00+00:00": 473.4100036621094
    },
    "sentiment": 0.9342552423477173
  },
  {
    "title": "3 Top-Rated Gene Editing Stocks Actually Making Money",
    "published": 1720033918,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 477.5199890136719,
      "2024-07-03T14:30:00+00:00": 471.510009765625,
      "2024-07-03T15:30:00+00:00": 469.2149963378906
    },
    "sentiment": 0.4967387914657593
  },
  {
    "title": "IN BRIEF: Vertex US application for cystic fibrosis treatment accepted",
    "published": 1719934740,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 469.760009765625,
      "2024-07-02T14:30:00+00:00": 471.8999938964844,
      "2024-07-02T15:30:00+00:00": 477.92999267578125,
      "2024-07-02T16:30:00+00:00": 475.9200134277344,
      "2024-07-02T17:30:00+00:00": 472.81500244140625,
      "2024-07-02T18:30:00+00:00": 474.75,
      "2024-07-02T19:30:00+00:00": 474.07501220703125
    },
    "sentiment": 0.8789371848106384
  },
  {
    "title": "Vertex to Announce Second Quarter 2024 Financial Results on August 1",
    "published": 1719864300,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 467.94000244140625,
      "2024-07-01T14:30:00+00:00": 476.45001220703125,
      "2024-07-01T15:30:00+00:00": 473.7900085449219,
      "2024-07-01T16:30:00+00:00": 472.0,
      "2024-07-01T17:30:00+00:00": 469.7049865722656,
      "2024-07-01T18:30:00+00:00": 470.7950134277344,
      "2024-07-01T19:30:00+00:00": 471.93499755859375
    },
    "sentiment": 0.9277815222740173
  },
  {
    "title": "3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow",
    "published": 1725011400,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 495.6700134277344,
      "2024-08-30T14:30:00+00:00": 497.6650085449219,
      "2024-08-30T15:30:00+00:00": 494.010009765625,
      "2024-08-30T16:30:00+00:00": 492.9200134277344,
      "2024-08-30T17:30:00+00:00": 496.114990234375,
      "2024-08-30T18:30:00+00:00": 495.7699890136719,
      "2024-08-30T19:30:00+00:00": 498.30999755859375
    },
    "sentiment": 0.9393037557601929
  },
  {
    "title": "Looking Into Vertex Pharmaceuticals's Recent Short Interest",
    "published": 1724759520,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 482.760009765625,
      "2024-08-27T14:30:00+00:00": 479.8500061035156,
      "2024-08-27T15:30:00+00:00": 477.5450134277344,
      "2024-08-27T16:30:00+00:00": 477.2799987792969,
      "2024-08-27T17:30:00+00:00": 476.989990234375,
      "2024-08-27T18:30:00+00:00": 478.61248779296875,
      "2024-08-27T19:30:00+00:00": 479.6050109863281
    },
    "sentiment": 0.9396603107452393
  },
  {
    "title": "3 US Stocks That May Be Trading Below Estimated Value In August 2024",
    "published": 1724410968,
    "day_prices": {
      "2024-08-23T13:30:00+00:00": 482.3900146484375,
      "2024-08-23T14:30:00+00:00": 484.95001220703125,
      "2024-08-23T15:30:00+00:00": 485.3500061035156,
      "2024-08-23T16:30:00+00:00": 484.8999938964844,
      "2024-08-23T17:30:00+00:00": 482.7900085449219,
      "2024-08-23T18:30:00+00:00": 482.54998779296875,
      "2024-08-23T19:30:00+00:00": 483.8900146484375
    },
    "sentiment": 0.8182919025421143
  },
  {
    "title": "Vertex to Participate in Upcoming September Investor Conferences",
    "published": 1724328000,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 486.4700012207031,
      "2024-08-22T14:30:00+00:00": 483.42498779296875,
      "2024-08-22T15:30:00+00:00": 484.25,
      "2024-08-22T16:30:00+00:00": 483.5470886230469,
      "2024-08-22T17:30:00+00:00": 481.9100036621094,
      "2024-08-22T18:30:00+00:00": 482.70001220703125,
      "2024-08-22T19:30:00+00:00": 481.8599853515625
    },
    "sentiment": 0.9055730104446411
  },
  {
    "title": "RMR Group announces early renewal of Vertex Pharmaceuticals lease",
    "published": 1724051640,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 477.010009765625,
      "2024-08-19T14:30:00+00:00": 482.19000244140625,
      "2024-08-19T15:30:00+00:00": 485.36749267578125,
      "2024-08-19T16:30:00+00:00": 482.07000732421875,
      "2024-08-19T17:30:00+00:00": 484.6000061035156,
      "2024-08-19T18:30:00+00:00": 484.80999755859375,
      "2024-08-19T19:30:00+00:00": 485.7650146484375
    },
    "sentiment": 0.8903207182884216
  },
  {
    "title": "3 Fantastic Growth Stocks to Buy in August",
    "published": 1723894200,
    "day_prices": {},
    "sentiment": 0.8954088091850281
  },
  {
    "title": "Vortex Energy Advances Drilling at Salt Project",
    "published": 1723721940,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 471.44000244140625,
      "2024-08-15T14:30:00+00:00": 470.9049987792969,
      "2024-08-15T15:30:00+00:00": 473.2799987792969,
      "2024-08-15T16:30:00+00:00": 472.9599914550781,
      "2024-08-15T17:30:00+00:00": 473.1000061035156,
      "2024-08-15T18:30:00+00:00": 472.0950012207031,
      "2024-08-15T19:30:00+00:00": 471.5400085449219
    },
    "sentiment": 0.8538825511932373
  },
  {
    "title": "Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them",
    "published": 1723715100,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 471.44000244140625,
      "2024-08-15T14:30:00+00:00": 470.9049987792969,
      "2024-08-15T15:30:00+00:00": 473.2799987792969,
      "2024-08-15T16:30:00+00:00": 472.9599914550781,
      "2024-08-15T17:30:00+00:00": 473.1000061035156,
      "2024-08-15T18:30:00+00:00": 472.0950012207031,
      "2024-08-15T19:30:00+00:00": 471.5400085449219
    },
    "sentiment": 0.8908191919326782
  },
  {
    "title": "Crispr's Casgevy Launch: Promising Start, Uncertain Future",
    "published": 1723615730,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 465.3399963378906,
      "2024-08-14T14:30:00+00:00": 470.5299987792969,
      "2024-08-14T15:30:00+00:00": 470.2300109863281,
      "2024-08-14T16:30:00+00:00": 471.1099853515625,
      "2024-08-14T17:30:00+00:00": 469.82000732421875,
      "2024-08-14T18:30:00+00:00": 469.875,
      "2024-08-14T19:30:00+00:00": 470.55999755859375
    },
    "sentiment": 0.6287556886672974
  },
  {
    "title": "2 Biotech Stocks To Watch In August 2024",
    "published": 1723595816,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 465.3399963378906,
      "2024-08-14T14:30:00+00:00": 470.5299987792969,
      "2024-08-14T15:30:00+00:00": 470.2300109863281,
      "2024-08-14T16:30:00+00:00": 471.1099853515625,
      "2024-08-14T17:30:00+00:00": 469.82000732421875,
      "2024-08-14T18:30:00+00:00": 469.875,
      "2024-08-14T19:30:00+00:00": 470.55999755859375
    },
    "sentiment": 0.9164355993270874
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Vertex Pharmaceuticals",
    "published": 1723542900,
    "day_prices": {
      "2024-08-13T13:30:00+00:00": 463.489990234375,
      "2024-08-13T14:30:00+00:00": 462.5249938964844,
      "2024-08-13T15:30:00+00:00": 461.8699951171875,
      "2024-08-13T16:30:00+00:00": 466.3599853515625,
      "2024-08-13T17:30:00+00:00": 467.1199951171875,
      "2024-08-13T18:30:00+00:00": 467.4100036621094,
      "2024-08-13T19:30:00+00:00": 467.3800048828125
    },
    "sentiment": 0.932876467704773
  },
  {
    "title": "Renaissance Technologies Amplifies Stake in Broadcom Inc in Q2 2024",
    "published": 1723460520,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 466.9599914550781,
      "2024-08-12T14:30:00+00:00": 465.3299865722656,
      "2024-08-12T15:30:00+00:00": 463.614990234375,
      "2024-08-12T16:30:00+00:00": 463.4700012207031,
      "2024-08-12T17:30:00+00:00": 465.70001220703125,
      "2024-08-12T18:30:00+00:00": 462.9939880371094,
      "2024-08-12T19:30:00+00:00": 463.69000244140625
    },
    "sentiment": 0.8854044675827026
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals",
    "published": 1723168140,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 465.04998779296875,
      "2024-08-09T14:30:00+00:00": 469.0849914550781,
      "2024-08-09T15:30:00+00:00": 466.67999267578125,
      "2024-08-09T16:30:00+00:00": 466.30999755859375,
      "2024-08-09T17:30:00+00:00": 468.8500061035156,
      "2024-08-09T18:30:00+00:00": 465.8399963378906,
      "2024-08-09T19:30:00+00:00": 467.42498779296875
    },
    "sentiment": 0.9252616167068481
  },
  {
    "title": "Merck TIGIT drug fails another trial; Intellia therapy succeeds in HAE study",
    "published": 1723134180,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 468.3699035644531,
      "2024-08-08T14:30:00+00:00": 466.55999755859375,
      "2024-08-08T15:30:00+00:00": 465.3999938964844,
      "2024-08-08T16:30:00+00:00": 465.05999755859375,
      "2024-08-08T17:30:00+00:00": 472.30499267578125,
      "2024-08-08T18:30:00+00:00": 471.0849914550781,
      "2024-08-08T19:30:00+00:00": 466.3599853515625
    },
    "sentiment": 0.5427133440971375
  },
  {
    "title": "Vertex's gene-editing therapy recommended for NHS England",
    "published": 1723082040,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 468.3699035644531,
      "2024-08-08T14:30:00+00:00": 466.55999755859375,
      "2024-08-08T15:30:00+00:00": 465.3999938964844,
      "2024-08-08T16:30:00+00:00": 465.05999755859375,
      "2024-08-08T17:30:00+00:00": 472.30499267578125,
      "2024-08-08T18:30:00+00:00": 471.0849914550781,
      "2024-08-08T19:30:00+00:00": 466.3599853515625
    },
    "sentiment": 0.6372269988059998
  },
  {
    "title": "Vertex Announces CASGEVY\u2122 Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England",
    "published": 1723072320,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 476.75,
      "2024-08-07T14:30:00+00:00": 467.9599914550781,
      "2024-08-07T15:30:00+00:00": 471.19000244140625,
      "2024-08-07T16:30:00+00:00": 469.0400085449219,
      "2024-08-07T17:30:00+00:00": 465.6600036621094,
      "2024-08-07T18:30:00+00:00": 466.3500061035156,
      "2024-08-07T19:30:00+00:00": 468.2699890136719
    },
    "sentiment": 0.877034068107605
  },
  {
    "title": "Vertex Announces CASGEVY? Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England",
    "published": 1723057920,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 476.75,
      "2024-08-07T14:30:00+00:00": 467.9599914550781,
      "2024-08-07T15:30:00+00:00": 471.19000244140625,
      "2024-08-07T16:30:00+00:00": 469.0400085449219,
      "2024-08-07T17:30:00+00:00": 465.6600036621094,
      "2024-08-07T18:30:00+00:00": 466.3500061035156,
      "2024-08-07T19:30:00+00:00": 468.2699890136719
    },
    "sentiment": 0.8348349928855896
  },
  {
    "title": "Vertex Pharmaceuticals annoucnes Casgevy reimbursement agreement in England",
    "published": 1723012560,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 476.75,
      "2024-08-07T14:30:00+00:00": 467.9599914550781,
      "2024-08-07T15:30:00+00:00": 471.19000244140625,
      "2024-08-07T16:30:00+00:00": 469.0400085449219,
      "2024-08-07T17:30:00+00:00": 465.6600036621094,
      "2024-08-07T18:30:00+00:00": 466.3500061035156,
      "2024-08-07T19:30:00+00:00": 468.2699890136719
    },
    "sentiment": 0.6813315153121948
  },
  {
    "title": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know",
    "published": 1722949212,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 474.010009765625,
      "2024-08-06T14:30:00+00:00": 477.82501220703125,
      "2024-08-06T15:30:00+00:00": 480.7300109863281,
      "2024-08-06T16:30:00+00:00": 478.2900085449219,
      "2024-08-06T17:30:00+00:00": 476.25,
      "2024-08-06T18:30:00+00:00": 478.4800109863281,
      "2024-08-06T19:30:00+00:00": 476.0799865722656
    },
    "sentiment": 0.9459224939346313
  },
  {
    "title": "Tweedy Browne Funds' 2nd-Quarter Commentary: A Reflection",
    "published": 1722912420,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 474.010009765625,
      "2024-08-06T14:30:00+00:00": 477.82501220703125,
      "2024-08-06T15:30:00+00:00": 480.7300109863281,
      "2024-08-06T16:30:00+00:00": 478.2900085449219,
      "2024-08-06T17:30:00+00:00": 476.25,
      "2024-08-06T18:30:00+00:00": 478.4800109863281,
      "2024-08-06T19:30:00+00:00": 476.0799865722656
    },
    "sentiment": 0.9414083361625671
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Gets a Buy from Oppenheimer",
    "published": 1722840540,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 472.2749938964844,
      "2024-08-05T14:30:00+00:00": 475.3599853515625,
      "2024-08-05T15:30:00+00:00": 475.94000244140625,
      "2024-08-05T16:30:00+00:00": 482.8399963378906,
      "2024-08-05T17:30:00+00:00": 474.6300048828125,
      "2024-08-05T18:30:00+00:00": 477.7449951171875,
      "2024-08-05T19:30:00+00:00": 477.2900085449219
    },
    "sentiment": 0.5161260962486267
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Gets a Buy from Truist Financial",
    "published": 1722838680,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 472.2749938964844,
      "2024-08-05T14:30:00+00:00": 475.3599853515625,
      "2024-08-05T15:30:00+00:00": 475.94000244140625,
      "2024-08-05T16:30:00+00:00": 482.8399963378906,
      "2024-08-05T17:30:00+00:00": 474.6300048828125,
      "2024-08-05T18:30:00+00:00": 477.7449951171875,
      "2024-08-05T19:30:00+00:00": 477.2900085449219
    },
    "sentiment": 0.6158861517906189
  },
  {
    "title": "Vertex Pharmaceuticals just downgraded at Barclays, here's why",
    "published": 1722829140,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 472.2749938964844,
      "2024-08-05T14:30:00+00:00": 475.3599853515625,
      "2024-08-05T15:30:00+00:00": 475.94000244140625,
      "2024-08-05T16:30:00+00:00": 482.8399963378906,
      "2024-08-05T17:30:00+00:00": 474.6300048828125,
      "2024-08-05T18:30:00+00:00": 477.7449951171875,
      "2024-08-05T19:30:00+00:00": 477.2900085449219
    },
    "sentiment": 0.9053715467453003
  },
  {
    "title": "Analyst Issues Sell Rating on Vertex Pharmaceuticals Amid Maturing CF Products and Overvalued Pain Franchise",
    "published": 1722821400,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 472.2749938964844,
      "2024-08-05T14:30:00+00:00": 475.3599853515625,
      "2024-08-05T15:30:00+00:00": 475.94000244140625,
      "2024-08-05T16:30:00+00:00": 482.8399963378906,
      "2024-08-05T17:30:00+00:00": 474.6300048828125,
      "2024-08-05T18:30:00+00:00": 477.7449951171875,
      "2024-08-05T19:30:00+00:00": 477.2900085449219
    },
    "sentiment": 0.5367124676704407
  },
  {
    "title": "3 Biotech Stocks on Track for 50% Returns (or More) by 2028",
    "published": 1722792819,
    "day_prices": {},
    "sentiment": 0.8791724443435669
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?",
    "published": 1722691836,
    "day_prices": {},
    "sentiment": 0.6473948955535889
  },
  {
    "title": "Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now",
    "published": 1722681480,
    "day_prices": {},
    "sentiment": 0.65929114818573
  },
  {
    "title": "Compared to Estimates, Vertex (VRTX) Q2 Earnings: A Look at Key Metrics",
    "published": 1722636013,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.8911768198013306
  },
  {
    "title": "US Q2 earnings growth estimate dips, reflecting Vertex loss, LSEG says",
    "published": 1722614489,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.9733901023864746
  },
  {
    "title": "Vertex Pharmaceuticals (NASDAQ:VRTX) Slides despite Raising Revenue Guidance",
    "published": 1722603000,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.9330686330795288
  },
  {
    "title": "Vertex boosts revenue forecast on back of cystic fibrosis franchise growth",
    "published": 1722594480,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.9504014253616333
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $35 at Piper Sandler, here's why",
    "published": 1722589140,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.7267551422119141
  },
  {
    "title": "Morgan Stanley Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX)",
    "published": 1722585300,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.849822998046875
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $25 at TD Cowen, here's why",
    "published": 1722584040,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.7397220730781555
  },
  {
    "title": "Vertex Pharmaceuticals: Solid Performance but Uncertain Expansion Justifies Hold Rating",
    "published": 1722578280,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.7502846121788025
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: uniQure (QURE), Aurinia Pharmaceuticals (AUPH) and Vertex Pharmaceuticals (VRTX)",
    "published": 1722577500,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.9367904663085938
  },
  {
    "title": "Vertex Stock: Came For CF Drugs, Staying For Gene Therapy",
    "published": 1722575836,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.9177331924438477
  },
  {
    "title": "Buy Rating Affirmed for Vertex Pharmaceuticals Amid Strong Financials and Promising CF Treatments",
    "published": 1722569160,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 491.5,
      "2024-08-02T14:30:00+00:00": 497.8299865722656,
      "2024-08-02T15:30:00+00:00": 494.6499938964844,
      "2024-08-02T16:30:00+00:00": 493.0299987792969,
      "2024-08-02T17:30:00+00:00": 493.6000061035156,
      "2024-08-02T18:30:00+00:00": 495.0,
      "2024-08-02T19:30:00+00:00": 494.8399963378906
    },
    "sentiment": 0.9536446928977966
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates",
    "published": 1722546911,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.9737504720687866
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated 2024 Q2 - Results - Earnings Call Presentation",
    "published": 1722544661,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.9319833517074585
  },
  {
    "title": "Vertex: Q2 Earnings Snapshot",
    "published": 1722543112,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.6335039138793945
  },
  {
    "title": "Vertex Reports Second Quarter 2024 Financial Results",
    "published": 1722542460,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.8714548945426941
  },
  {
    "title": "Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever",
    "published": 1722521700,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.9173207879066467
  },
  {
    "title": "REGENXBIO releases new data on DMD drug ahead of earnings",
    "published": 1722508560,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.9292389750480652
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings: GAAP EPS $(13.92), Revenue $2. ...",
    "published": 1722484200,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.8466376662254333
  },
  {
    "title": "Vertex Pharmaceuticals reports Q2 EPS ($13.92), consensus $4.14",
    "published": 1722481800,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 495.8500061035156,
      "2024-08-01T14:30:00+00:00": 503.32501220703125,
      "2024-08-01T15:30:00+00:00": 505.9750061035156,
      "2024-08-01T16:30:00+00:00": 504.68499755859375,
      "2024-08-01T17:30:00+00:00": 507.6300048828125,
      "2024-08-01T18:30:00+00:00": 508.2099914550781,
      "2024-08-01T19:30:00+00:00": 507.69000244140625
    },
    "sentiment": 0.6674076318740845
  }
]